Zobrazeno 1 - 10
of 21
pro vyhledávání: '"David Lah"'
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Autor:
Bénédicte Caron, Philippe Seksik, Anthony Buisson, Pauline Wils, Guillaume Savoye, Carmen Stefanescu, David Laharie, Lucas Guillo, Vered Abitbol, Joelle Bonnet, Romain Altwegg, Lucine Vuitton, Driffa Moussata, Arnaud Bourreille, Amélie Biron, Cyrielle Gilletta, Mathurin Fumery, Stephane Nahon, Stephane Nancey, Houda Camara, Laurent Peyrin-Biroulet
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Several adalimumab preparations are now available for patients with inflammatory bowel disease (IBD). Comparative satisfaction and tolerability are unknown. Objectives: This study investigated IBD patient satisfaction with approved adalim
Externí odkaz:
https://doaj.org/article/7ca0c8a49c264203b43510c27bcad604
Autor:
Laura K. Godfrey, Jan Forster, Sven-Thorsten Liffers, Christopher Schröder, Johannes Köster, Leonie Henschel, Kerstin U. Ludwig, David Lähnemann, Marija Trajkovic-Arsic, Diana Behrens, Aldo Scarpa, Rita T. Lawlor, Kathrin E. Witzke, Barbara Sitek, Steven A. Johnsen, Sven Rahmann, Bernhard Horsthemke, Michael Zeschnigk, Jens T. Siveke
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-22 (2024)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor prognosis. It is marked by extraordinary resistance to conventional therapies including chemotherapy and radiation, as well as to essentially all targeted t
Externí odkaz:
https://doaj.org/article/d600d9b4f409474cb363cc7b8d335cf3
Autor:
Chanon Pornrungroj, Christopher Albanese, Sarah L. Stoll, Trevor Lyons, Jeffery A. Bertke, Vidumin Dahanayake, Yichien Lee, David Lah, William J. Hickling, Olga Rodriguez, Erika Parasido, Edward Van Keuren, Michele Pablico-Lansigan
Publikováno v:
ACS Applied Materials & Interfaces. 11:18153-18164
There is an increasing need for gadolinium-free magnetic resonance imaging (MRI) contrast agents, particularly for patients suffering from chronic kidney disease. Using a cluster–nanocarrier combin...
Autor:
David Lahna, Daniel Schwartz, Randy Woltjer, Sandra Black, Natalie Roese, Hiroko Dodge, Erin Boespflug, Julia Keith, Fuqiang Gao, Joel Ramirez, Lisa Silbert
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100098- (2024)
Externí odkaz:
https://doaj.org/article/cfe05c85aab04aaf934708fce320347d
Autor:
Vidumin, Dahanayake, Chanon, Pornrungroj, Michele, Pablico-Lansigan, William J, Hickling, Trevor, Lyons, David, Lah, Yichien, Lee, Erika, Parasido, Jeffery A, Bertke, Christopher, Albanese, Olga, Rodriguez, Edward, Van Keuren, Sarah L, Stoll
Publikováno v:
ACS Appl Mater Interfaces
There is an increasing need for gadolinium-free magnetic resonance imaging (MRI) contrast agents, particularly for patients suffering from chronic kidney disease. Using a cluster–nanocarrier combination, we have identified a novel approach to the d
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S392- (2023)
Externí odkaz:
https://doaj.org/article/06412f2c3f1e453ea56dc4cc35c272ba
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background The World Health Organization (WHO) cone bioassay is a key method used to evaluate the bioefficacy of long-lasting insecticidal nets (LLINs) used for malaria control. These tests also play an important role in LLIN product prequal
Externí odkaz:
https://doaj.org/article/1a3b36ce7fde404c846f78dbfde31c5e
Autor:
Margaux Lelong, Régis Josien, Marianne Coste-Burel, Marie Rimbert, Céline Bressollette-Bodin, Stéphane Nancey, Guillaume Bouguen, Matthieu Allez, Mélanie Serrero, Ludovic Caillo, Cléa Rouillon, Pierre Blanc, David Laharie, Raphaël Olivier, Laurent Peyrin-Biroulet, Nina Dib, Astrid De Maissin, Céline Montuclard, Caroline Trang-Poisson, Fabienne Vavasseur, Géraldine Gallot, Mathilde Berthome, Cécile Braudeau, Justine Chevreuil, Arnaud Bourreille, Catherine Le Berre
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPatients with inflammatory bowel disease (IBD) may have a modified immune response to SARS-CoV-2. The objectives were to evaluate the prevalence of COVID-19 in patients treated with infliximab or vedolizumab, to analyze the factors associat
Externí odkaz:
https://doaj.org/article/bb5aa4f5ef734067852b695ae42f61b4
Autor:
Aurelien Amiot, Anne Bourrier, Jean-Marc Gornet, Olivier Dewit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Charlotte Gagnière, Anthony Buisson, Maria Nachury, Stephanie Viennot, Lucine Vuitton, Carmen Stefanescu, Philippe Marteau, Guillaume Bouguen, Philippe Seksik
Publikováno v:
Infection Prevention in Practice, Vol 5, Iss 1, Pp 100267- (2023)
Summary: Background: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. Aim: To assess the risk of COVID-19 in healthcare workers wit
Externí odkaz:
https://doaj.org/article/77589efbbe5f4a03bea35dbb75ba4e58
Autor:
Aonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, David Laharie, Philippe Marteau, Xavier Treton, Matthieu Allez, Xavier Roblin, Georgia Malamut, Cyriane Oeuvray, Nathalie Rolhion, Xavier Dray, Dominique Rainteau, Antonin Lamaziere, Emilie Gauliard, Julien Kirchgesner, Laurent Beaugerie, Philippe Seksik, Laurent Peyrin-Biroulet, Harry Sokol
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
Due to the potential role of the gut microbiota and bile acids in the pathogenesis of both inflammatory bowel disease (IBD) and sporadic colorectal cancer, we aimed to determine whether these factors were associated with colorectal cancer in IBD pati
Externí odkaz:
https://doaj.org/article/61da1826966c4358b08e40865cc1ebf1